Development of a Database for Storage and Analysis of Factors Affecting Treatment of Hepatocellular Carcinoma

Persistent Link:
http://hdl.handle.net/10150/170534
Title:
Development of a Database for Storage and Analysis of Factors Affecting Treatment of Hepatocellular Carcinoma
Author:
Mitropanopoulos, Meg
Affiliation:
The University of Arizona College of Medicine - Phoenix
Issue Date:
Mar-2011
Rights:
Copyright © is held by the author. Digital access to this material is made possible by the College of Medicine - Phoenix, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author.
Collection Information:
This item is part of the College of Medicine - Phoenix Scholarly Projects 2011 collection. For more information, contact the Phoenix Biomedical Campus Library at pbc-library@email.arizona.edu.
Abstract:
Hepatocellular carcinoma (HCC) is the fifth most common solid tumor worldwide. There are 626,000 new cases per year of primary liver cancer worldwide, most of which are HCC. Over 1,000,000 people die of HCC per year, making HCC the third most frequent cause of cancer deaths worldwide1. Major etiologic factors associated with HCC include chronic HBV and HCV infection, chronic alcoholism, non-alcoholic steatohepatitis, and aflatoxin exposure. The standard treatment for HCC is surgical resection, however on presentation many patients have progressed to the point where such treatment is not an option, and are placed on liver transplant lists. Palliative treatment modalities are often used in the interim, including trans-arterial chemoembolization (TACE), radiofrequency ablation (RFA), or systemic chemotherapy. In this study over 200 patients who received either Therasphere or Sirsphere (TACE methods), or RFA treatment for unresectable HCC were catalogued in a relational database allowing for analysis of treatment outcomes and treatment comparisons. A Microsoft Access database was created to store data such as patient demographics, disease details, adverse events, patient lab values, treatment details, and pre- and post-lesion measurements. This database is currently in use by the department of Interventional Radiology at Banner Good Samaritan Medical Center.
MeSH Subjects:
Carcinoma, Hepatocellular; Databases, factual; Disease management
Description:
A Thesis submitted to The University of Arizona College of Medicine - Phoenix in partial fulfillment of the requirements for the Degree of Doctor of Medicine.
Mentor:
Wood, David, MD

Full metadata record

DC FieldValue Language
dc.language.isoen_USen_US
dc.titleDevelopment of a Database for Storage and Analysis of Factors Affecting Treatment of Hepatocellular Carcinomaen_US
dc.contributor.authorMitropanopoulos, Megen_US
dc.contributor.departmentThe University of Arizona College of Medicine - Phoenixen_US
dc.date.issued2011-03-
dc.rightsCopyright © is held by the author. Digital access to this material is made possible by the College of Medicine - Phoenix, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author.en_US
dc.description.collectioninformationThis item is part of the College of Medicine - Phoenix Scholarly Projects 2011 collection. For more information, contact the Phoenix Biomedical Campus Library at pbc-library@email.arizona.edu.en_US
dc.description.abstractHepatocellular carcinoma (HCC) is the fifth most common solid tumor worldwide. There are 626,000 new cases per year of primary liver cancer worldwide, most of which are HCC. Over 1,000,000 people die of HCC per year, making HCC the third most frequent cause of cancer deaths worldwide1. Major etiologic factors associated with HCC include chronic HBV and HCV infection, chronic alcoholism, non-alcoholic steatohepatitis, and aflatoxin exposure. The standard treatment for HCC is surgical resection, however on presentation many patients have progressed to the point where such treatment is not an option, and are placed on liver transplant lists. Palliative treatment modalities are often used in the interim, including trans-arterial chemoembolization (TACE), radiofrequency ablation (RFA), or systemic chemotherapy. In this study over 200 patients who received either Therasphere or Sirsphere (TACE methods), or RFA treatment for unresectable HCC were catalogued in a relational database allowing for analysis of treatment outcomes and treatment comparisons. A Microsoft Access database was created to store data such as patient demographics, disease details, adverse events, patient lab values, treatment details, and pre- and post-lesion measurements. This database is currently in use by the department of Interventional Radiology at Banner Good Samaritan Medical Center.en_US
dc.typeThesisen_US
dc.subject.meshCarcinoma, Hepatocellularen_US
dc.subject.meshDatabases, factualen_US
dc.subject.meshDisease managementen_US
dc.descriptionA Thesis submitted to The University of Arizona College of Medicine - Phoenix in partial fulfillment of the requirements for the Degree of Doctor of Medicine.en_US
dc.contributor.mentorWood, David, MDen_US
All Items in UA Campus Repository are protected by copyright, with all rights reserved, unless otherwise indicated.